[非小细胞肺癌的分子病理学:当前和新兴的生物标志物]
Helen Pasternack1, Jutta Kirfel2
1Institut für Pathologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Deutschland.
Pathologie (Heidelberg, Germany)
|April 3, 2025
概括
肺癌的治疗进展有针对性的药物和免疫疗法,由分子诊断驱动. 识别瘤中的遗传"驱动因素"可以实现个性化,有效的肺癌疗法.
科学领域:
- 在瘤学瘤学.
- 分子病理学分子病理学
- 遗传学 遗传学 是一个
背景情况:
- 肺癌的分类依赖于区分小细胞和非小细胞癌.
- 瘤发生受到癌细胞内的特定遗传变异的显著影响,称为"驱动因素".
- 最近的进展包括针对性药物和肺癌的免疫调节疗法.
研究的目的:
- 为了突出肺癌治疗的不断变化的景观.
- 强调分子病理诊断在个性化医学中的关键作用.
- 强调识别基因驱动因素对于向治疗选择的重要性.
主要方法:
- 审查当前的肺癌分类和治疗模式.
- 分析遗传驱动因素对瘤生长和治疗反应的影响.
- 讨论越来越需要在病理学中进行全面的生物标志物分析.
主要成果:
- 在过去的十年中,向药物和免疫疗法已成为肺癌治疗的组成部分.
- 这些方法导致了更加个性化和差异化的治疗策略.
- 分子病理诊断对于识别可操作的生物标志物至关重要.
结论:
- 鉴定遗传驱动因素对于有效的肺癌管理至关重要.
- 个性化治疗策略越来越依赖于分子诊断.
- 病理学在促进肺癌精确瘤学的发展中发挥着核心作用.
更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K